for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Diaceutics PLC

DXRX.L

Latest Trade

113.50GBp

Change

-3.00(-2.58%)

Volume

15,900

Today's Range

--

 - 

--

52 Week Range

91.00

 - 

195.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
116.50
Open
116.50
Volume
15,900
3M AVG Volume
0.82
Today's High
--
Today's Low
--
52 Week High
195.00
52 Week Low
91.00
Shares Out (MIL)
84.07
Market Cap (MIL)
95.42
Forward P/E
-40.54
Dividend (Yield %)
--

Next Event

Diaceutics PLC Annual Shareholders Meeting

Latest Developments

More

Diaceutics H1 Adjusted EBITDA 300,000 Stg Vs Loss Of 300,000 Stg

Diaceutics Announces New Contract Win For DXRX Platform

Diaceutics Says Sales For First Half Increased By 20%

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Diaceutics PLC

Diaceutics PLC is a United Kingdom-based data analytics and implementation services company which services the global pharmaceutical industry. The Company offers end to end services that encompasses from understanding the diagnostic landscape to test implementation into treatment pathways to enable better treatment decisions for patients. The Company’s data analytics and implementation services, including Landscape, Tracking, and Primary Market Research, leverages the diagnostic testing information to provide data-driven insights to drive seamless integration of diagnostic tests into treatment pathways. Its implementation services include Planning, Commercialization and Reimbursement Landscapes, to build the strategies and implement the tactics that drives optimal test utilization, ensuring that patients are getting the right treatment.

Industry

Computer Services

Contact Info

727 Antrim Road

BELFAST, NIR

BT2 8FE

United Kingdom

https://www.diaceutics.com/

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2019

0.0K

2020(E)

0.0K
EPS (GBp)

2019

2.450

2020(E)

-2.800
Price To Earnings (TTM)
24.87
Price To Sales (TTM)
6.64
Price To Book (MRQ)
2.32
Price To Cash Flow (TTM)
26.11
Total Debt To Equity (MRQ)
0.27
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
10.81
Return on Equity (TTM)
10.24

Latest News

Latest News

BRIEF-Diaceutics Says Sales For First Half Increased By 20%

* DIACEUTICS PLC - SALES FOR FIRST HALF INCREASED BY 20 PER CENT. TO £5.3 MILLION Source text for Eikon: Further company coverage:

UPDATE 1-UK Stocks-Factors to watch on Sept. 9

Britain's FTSE 100 index is seen opening up 22 points to 7,304 on Monday, according to financial bookmakers, with futures trading up 0.5%.

UK Stocks-Factors to watch on Sept. 9

Britain's FTSE 100 index is seen opening up 22 points to 7,304 on Monday, according to financial bookmakers, with futures trading up 0.3% at 7307. * BRITISH AIRWAYS: British Airways pilots began a 48-hour strike on Monday, grounding most of the airline's flights and disrupting...

Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'

In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a "Lazarus effect" in some patients because it can reverse late-stage cancer that has defied all other treatment options.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up